The incidence of sporadic vestibular schwannoma has significantly increased over the past few decades. However, there is no method currently available to accurately predict the risk of subsequent tumor growth. The difference in the management of five patient groups has been evaluated: wait and scan, conversion to microsurgery, conversion to stereoradiotherapy, sterioradiotherapy, and microsurgery. In total, 463 patients with vestibular schwannoma have been consulted in our department from 2010 through 2016. Of the 250 patients initially indicated for observation, 32.4% were later indicated for active treatment. Younger patients were more frequently indicated for surgery (mean age 48 years) compared to older patients, who were more often indicated for stereoradiotherapy (mean age 62 years). Tumor growth was observed more often in patients under 60 years of age and in patients with tumors greater than 10 mm. In elderly patients, including those with larger tumors, a conservative approach is the optimal solution. If tumor growth occurs in the wait-and-scan strategy, it is still possible to continue with a conservative approach in some situations. The duration of follow-up scans is still a matter of debate, as tumors can begin to grow after 5 years from the initial diagnosis.

Department of Neurosurgery 2nd Faculty of Medicine Charles University and Motol University Hospital 15006 Prague Czech Republic

Department of Otorhinolaryngology 2nd Faculty of Medicine Charles University and University Hospital Královské Vinohrady 10034 Prague Czech Republic

Department of Otorhinolaryngology and Head and Neck Surgery 1st Faculty of Medicine Charles University and Motol University Hospital 15006 Prague Czech Republic

Zobrazit více v PubMed

Reddy C.E., Lewis-Jones H.G., Javadpour M., Ryland I., Lesser T.H. Conservative management of vestibular schwannomas of 15 to 31 mm intracranial diameter. J. Laryngol. Otol. 2014;128:752–758. doi: 10.1017/S0022215114001315. PubMed DOI

Fik Z., Lazak J., Hruba S., Cada Z., Zverrna E., Betka J. Hearing improvement after vestibular schwannoma surgery in the era of the hearing preservation rule—Case report and literature review. Biomed. Pap. 2022;166:347–352. doi: 10.5507/bp.2021.067. PubMed DOI

Waterval J., Kania R., Somers T. EAONO Position Statement on Vestibular Schwannoma: Imaging Assessment. What are the Indications for Performing a Screening MRI Scan for a Potential Vestibular Schwannoma? J. Int. Adv. Otol. 2018;14:95–99. doi: 10.5152/iao.2018.5364. PubMed DOI PMC

Marinelli J.P., Lohse C.M., Grossardt B.R., Lane J.I., Carlson M.L. Rising Incidence of Sporadic Vestibular Schwannoma: True Biological Shift Versus Simply Greater Detection. Otol. Neurotol. 2020;41:813–847. doi: 10.1097/MAO.0000000000002626. PubMed DOI PMC

Marinelli J.P., Nassiri A.M., Habermann E.B., Lohse C.M., Holton S.J., Carlson M.L. Underreporting of Vestibular Schwannoma Incidence Within National Brain Tumor and Cancer Registries in the United States. Otol. Neurotol. 2021;42:e758–e763. doi: 10.1097/MAO.0000000000003049. PubMed DOI PMC

Goldbrunner R., Weller M., Regis J., Lund-Johansen M., Stavrinou P., Reuss D., Evans D.G., Lefranc F., Sallabanda K., Falini A., et al. EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro-Oncology. 2020;22:31–45. doi: 10.1093/neuonc/noz153. PubMed DOI PMC

Huang X., Caye-Thomasen P., Stangerup S.-E. Spontaneous tumour shrinkage in 1261 observed patients with sporadic vestibular schwannoma. J. Laryngol. Otol. 2013;127:739–743. doi: 10.1017/S0022215113001266. PubMed DOI

Thielhelm T.P., Goncalves S., Welford S.M., Mellon E.A., Cohen E.R., Nourbakhsh A., Fernandez-Valle C., Telischi F., Ivan M.E., Dinh C.T. Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation Resistance. Cancers. 2021;13:4575. doi: 10.3390/cancers13184575. PubMed DOI PMC

Betka J., Zverina E., Lisy J., Chovanec M., Kluh J., Kraus J. Vestibulární schwannom [Vestibular schwannoma] Otorinolaryng Foniat. 2008;57:221–225.

Roehm P.C., Gantz B.J. Management of Acoustic Neuromas in Patients 65 Years or Older. Otol. Neurotol. 2007;28:708–714. doi: 10.1097/01.mao.0000281805.44197.ec. PubMed DOI

Kanzaki J., Tos M., Sanna M., Moffat D.A., Monsell E.M., Berliner K.I. New and Modified Reporting Systems from the Consensus Meeting on Systems for Reporting Results in Vestibular Schwannoma. Otol. Neurotol. 2003;24:642–649. doi: 10.1097/00129492-200307000-00019. PubMed DOI

Gupta V.K., Thakker A., Gupta K.K. Vestibular Schwannoma: What We Know and Where We are Heading. Head Neck Pathol. 2020;14:1058–1066. doi: 10.1007/s12105-020-01155-x. PubMed DOI PMC

D’Haese S., Parmentier H., Keppler H., Van Vooren S., Van Driessche V., Bauters W., Van Roost D., Dhooge I. Vestibular schwannoma: Natural growth and possible predictive factors. Acta Oto-Laryngol. 2019;139:753–758. doi: 10.1080/00016489.2019.1635268. PubMed DOI

Hughes M., Skilbeck C., Saeed S., Bradford R. Expectant Management of Vestibular Schwannoma: A Retrospective Multivariate Analysis of Tumor Growth and Outcome. Skull Base. 2011;21:295–302. doi: 10.1055/s-0031-1284219. PubMed DOI PMC

Kleijwegt M., Bettink F., Malessy M., Putter H., van der Mey A. Clinical Predictors Leading to Change of Initial Conservative Treatment of 836 Vestibular Schwannomas. J. Neurol. Surg. Part B Skull Base. 2020;81:15–21. doi: 10.1055/s-0039-1678708. PubMed DOI PMC

Reznitsky M., Petersen M., West N., Stangerup S.-E., Cayé-Thomasen P. The natural history of vestibular schwannoma growth—Prospective 40-year data from an unselected national cohort. Neuro-Oncology. 2021;23:827–836. doi: 10.1093/neuonc/noaa230. PubMed DOI PMC

Sethi M., Borsetto D., Cho Y., Gair J., Gamazo N., Jefferies S., Joannides A., Mannion R., Helmy A., Axon P., et al. The Conditional Probability of Vestibular Schwannoma Growth at Different Time Points After Initial Stability on an Observational Protocol. Otol. Neurotol. 2020;41:250–257. doi: 10.1097/MAO.0000000000002448. PubMed DOI

Hentschel M.A., Hannink G., Steens S.C.A., Mulder J.J.S., Rovers M.M., Kunst H.P.M. Development of a model to predict vestibular schwannoma growth: An opportunity to introduce new wait and scan strategies. Clin. Otolaryngol. 2021;46:273–283. doi: 10.1111/coa.13661. PubMed DOI PMC

Borsetto D., Gair J., Kenyon O., Das T., Donnelly N., Axon P., Macfarlane R., Mannion R., Scoffings D., Bance M., et al. When Should We Stop Scanning Older Patients with Vestibular Schwannomas? J. Neurol. Surg. Part B Skull Base. 2019;80:333–337. doi: 10.1055/s-0038-1676820. PubMed DOI PMC